Prof. Dr. Peter Goebell



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer (2024) Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BW, Stenzl A, et al. Journal article, Review article 25 years International Bladder Cancer Network (IBCN): The past, the present, and the future (2023) Dyrskjøt L, Vlahou A, Black PC, Droller M, Grossmann HB, Goebell P, Kamat AM, et al. Journal article, Review article Axitinib beyond first-line therapy of Metastatic Renal Cell Carcinoma: Real World Data from the STAR-TOR registry (2023) Uhlig A, Uhlig J, Woike M, Fischer T, Trojan L, Bergmann L, Bögemann M, et al. Journal article Geriatrisches Assessment – Was sollte vor Therapiebeginn des mHSPC und des mCRPC gemacht und bedacht werden? (2023) Heers H, Butea-Bocu MC, Groeben C, Huber J, Wullich B, Goebell P, Fiebig C Journal article Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma (2023) Kümmerl L, Kraulich M, Lesyuk W, Binninger A, Goebell P, Kahlmeyer A Journal article Individualisierte Präzisionsmedizin (2023) Wullich B, Taubert H, Goebell P, Kuwert T, Beck M, Schott C, Baur A, et al. Journal article, Review article Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1 (2023) Hensley PJ, Seiler R, Herr H, Mouw KW, Iyer G, Dyrskjøt L, Nawroth R, et al. Journal article, Review article Editorial: Cutting edge basic and clinical bladder cancer research – the IBCN updates (2023) Goebell P, Kamat AM, Black PC, Dyrskjøt L, Nawroth R, Seiler R, Todenhöfer T, et al. Journal article, Review article Thrombospondin-2 and LDH: potential predictive biomarkers for the treatment of metastatic renal cell carcinoma with everolimus after one VEGF-targeted therapy (MARC-2 study) (2022) Zeuschner P, Hoelters S, Stoeckle M, Seliger B, Mueller A, Bachmann HS, Gruenwald V, et al. Conference contribution Sequential treatment patterns over time for advanced renal cell carcinoma: data from the German research platform CARAT (2022) Goebell P, Gruellich C, Mueller L, Boegemann M, Martens U, Von Der Heyde E, Reichert D, et al. Conference contribution